Screener
Mineralys Therapeutics, Inc. MLYS Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Mineralys Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 5:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001933414-26-000084
FAQ
- What is Mineralys Therapeutics, Inc.'s price / book?
- Mineralys Therapeutics, Inc. (MLYS) reported price / book of 3.5× in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s price / book changed year-over-year?
- Mineralys Therapeutics, Inc.'s price / book increased by 19.8% year-over-year, from 2.9× to 3.5×.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s price / book?
- Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s price / book has grown at a 76.2% compound annual growth rate (CAGR), from 1.4× to 4.4×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Mineralys Therapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude